Dr. Nina Bhardwaj is an immunologist whose pioneering research on human dendritic cells transformed understanding of how the immune system recognizes and attacks cancer. At the Icahn School of Medicine at Mount Sinai, she helped bridge basic immunology and clinical medicine, laying the scientific foundation for dendritic cell-based cancer immunotherapies and therapeutic vaccines. Her work has advanced one of the most promising fields in modern oncology. In recognition of her contributions to medicine, she was elected to the National Academy of Medicine in 2024.
